Immunology/ Transplantation. Epidemiology/ Genetics
|
|
- Elijah Webster
- 5 years ago
- Views:
Transcription
1 FRIDAY, JUNE 22, 2018 Registration Hours: 9:00 a.m. 6:30 p.m. Shop Store Hours: 9:00 a.m. 6:30 p.m. 11:30 a.m. 12:30 p.m. Mini- Measuring Neuropathy Is Corneal Confocal Microscopy Ready for Prime Time? Mini- Biofilm Real Wound Problem or Just a Buzzword? Mini- Tech and Teens Mini- Myth or Science? Current Fads and Evidence in Diet and Nutrition Mini- Innovations in Pregnancy Care Mini- New-Onset Type 2 in the Youngest and the Oldest Mini- The Emerging Role of Neoepitopes in the Dialogue between T Cells and Beta Cells Mini- The Banting Exchange New Concepts in the Pathogenesis of and Metabolic Disease Mini- New Regulators of Beta-Cell Identity 12:45 p.m. 1:45 p.m. Mini- Surveillance of Kidney Disease and Comorbidities among People with What We Can Learn from the CDC s Chronic Kidney Disease Surveillance System Mini- Understanding Hybrid Closed-Loop Pump Mini- Youth-Onset Type 2 and Exercise Outcomes and Challenges Mini- Improving Patient-Provider Communication in the Management of in Culturally Diverse Populations Mini- Better Ways to Build Population Health Management Mini- Challenging Times for Youth with Type 1 How Do We Approach Them? Mini- The Future of Islet Transplant Towards a Renewable Source of Beta Cells Mini- Near, Far, Wherever You Are Obesity-Related Defects in Insulin Signaling Mini- Of Mice, Mongrels, and Men Commonalities and Differences in Metabolic Research
2 FRIDAY, JUNE 22, 2018 (CONTINUED) Registration Hours: 9:00 a.m. 6:30 p.m. Shop Store Hours: 9:00 a.m. 6:30 p.m. 2:00 p.m. 4:00 p.m. Antiplatelet and Antithrombotic Therapies in Decreasing Risk for Type 2 with Foods Artificial Pancreas and Decision Support Approaches Real-World Evidence in Mental Health Disorders and Distress among Adults with Endocrine, Paracrine Signaling Affecting Adipocyte Function The Exosome Superhighway in Energy and Metabolic Homeostasis Transformational Technologies in Islet Biology From Omics to Imaging 4:15 p.m. 6:15 p.m. The Many Faces of Hypoglycemia Impact on Patient Health and Well-Being Data, Data, Everywhere and Not a Pattern to Be Found Current Issues (4:15 p.m. 5:10 p.m.) Cardiovascular Outcomes Trials (CVOTs) in Shall We Continue or Change Course?, Adipose Tissue, Obesity, and Type 2 Novel Approaches to Advancing Islet Basic Science Adipose Differentiation and Function DiRECT Links between Hepatic Metabolism, Glucagon Action, and Glucose Turnover Balancing Proliferation and Maturation in the Islet (With ADA Presidents Select Abstract) Dynamic Approaches to Improve Glycemic Control and Primary Care Glucose Monitoring Advances, Pitfalls, and Clinical Relevance Current Issues (5:20 p.m. 6:15 p.m.) Should Metformin Remain the First- Line Therapy for Type 2? 6:30 p.m. 8:30 p.m. Networking Reception Orange County Convention Center (Level 4 Foyer)
3 SATURDAY, JUNE 23, 2018 Registration Hours: 7:00 a.m. 6:30 p.m. Shop Store Hours: 7:30 a.m. 6:15 p.m. Exhibit Hall Hours: 10:00 a.m. 4:00 p.m. Poster Hall Hours: 10:00 a.m. 6:00 p.m. 8:00 a.m. 10:00 a.m. Is It Osteomyelitis or Not? Diagnostic and Treatment Dilemmas in Bone Infection What s New in Diabetic Neuropathy? Equal Parts Clinical and Basic Science ADA Education Recognition Program Implementing Technology-Enabled Care Management Processes for Population Health Conception, Build, Implementation, Outcomes, and Sustainability Have You Seen Your Mother, Baby? Placenta- Derived Biomarkers of Adverse Pregnancy Outcomes in Gestational Mellitus and Type 2 in Youth HIV and The Double Whammy Overcoming Challenges in Islet Engineering and Protecting Beta Cells Hepatokines and Metabolic Regulation A Liver- Centric Point of View Turning Up the Heat New Regulators of Thermogenesis in Mice and Humans Targeting Beta-Cell Apoptosis and Death Effects of Exercise on Metabolic Health in Type 1 and Type 2 (With ADA Presidents Select Abstract) ADA Care Using Continuous Glucose Monitoring and Smart Devices to Control Glucose when It Matters Most Emerging Targets for Treatment 10:15 a.m. 11:15 a.m. President, Health Care & Education Address and Outstanding Educator in Award Lecture 11:30 a.m. 12:30 p.m. The Best and Worst Practices in Managing the Diabetic Foot Update on Nonnutritive Sweeteners and Cardiometabolic Health Mini- Quantifying Genomics, Electronic Health Records, and Automated Control Reframing Exercise The Surprising Science behind Motivating Patients to Be More Physically Active 11:30 a.m. 12:30 p.m. General Poster Session Hall WA4-WB2 (Poster Hall) 11:30 a.m. 1:30 p.m. Moderated Poster Discussions Hall WA4-WB2 (Poster Hall)/Hall WA1-WA3 (Exhibit Hall)
4 Registration Hours: 7:00 a.m. 6:30 p.m. Shop Store Hours: 7:30 a.m. 6:15 p.m. DAY-AT-A-GLANCE SCHEDULE SATURDAY, JUNE 23, 2018 (CONTINUED) Exhibit Hall Hours: 10:00 a.m. 4:00 p.m. Poster Hall Hours: 10:00 a.m. 6:00 p.m. 1:45 p.m. 3:45 p.m. The Resurgence of Triglyceride-Rich Lipoproteins as an Important Target in the Treatment of Dyslipidemia What Is New in Diabetic Kidney Disease? (With Stateof-the-Art Lecture and ADA Presidents Select Abstract) Making a Difference in Five Minutes Interventions in for Anyone (With Richard R. Rubin Award Lecture) Role of Exercise in Regulating Mitochondrial Dynamics National Implementation and Dissemination of Research to Improve Patient Safety and Reduce Hypoglycemia The Do-It-Yourself (DIY) Revolution Exploring the Next Frontier in Pharmacology Lessons Learned from the Environmental Determinants of in the Young (TEDDY) Study Insights into Early Autoimmune Type 1 Case Studies Monogenic Testing Is Ready for Prime Time Integrating into Your Practice New Insights into the Immunology of Human Type 1 The Intestine in the Regulation of Metabolism, Immunity, and Insulin Sensitivity Steering the Right Course for Management Clinical Perspectives Beta-Cell Dedifferentiation True or False? 4:00 p.m. 6:00 p.m. Hypoglycemia Reducing the Risk Research Advances in the Diabetic Foot (With Roger Pecoraro Award Lecture) Nutrition and the Gut Microbiome Online and Mobile Support Wading through the Noise Joint ADA/ISPAD 25 Years after the Announcement of the DCCT Results What Is the Status of Type 1 in Youth, and How Can We Do Better? Joint ADA/Chinese Society Glucose and Lipid Metabolism Novel Mechanisms and Targets It s Not Too Late, Baby Outcomes in Gestational Mellitus (With Norbert Freinkel Award Lecture) Updates from Type 2 Trials The Impact of Interventions and Behaviors on Outcomes Clinical Progress in Islet Clinical Science Mitochondrial Dynamics, Metabolism, and Insulin Action G is for GLP, GIP, and Glucagon A NOD to the Gut Liver Axis Muscling In on the Heart of Metabolism and Insulin Sensitivity Neurotransmitters in the Islet
5 Registration Hours: 7:30 a.m. 5:00 p.m. Shop Store Hours: 7:30 a.m. 6:45 p.m. DAY-AT-A-GLANCE SCHEDULE SUNDAY, JUNE 24, 2018 WEAR RED DAY Exhibit Hall Hours: 10:00 a.m. 4:00 p.m. Poster Hall Hours: 7:30 a.m. 6:30 p.m. 8:00 a.m. 10:00 a.m. The Where and Why of Diabetic Neuropathy Blood Flow to the Toe Prediction and Prevention of Cardiovascular Disease Building a Case for Getting Reimbursement or Payment for Behavioral Health in NDEP Prevention, Care, and Education in the Digital Age Unrecognized (Occult) Metabolic Conditions in Women with Gestational Mellitus that Predict Metabolic Later in Life Prioritizing Injectable Therapies in Type 2 and Risk Factors Challenges and Hope in Finding a Cure for Type 1 Molecular Mechanisms of Insulin Action and Resistance in Peripheral Tissues Precision Medicine in ADA Emerging Areas of Islet Biology Novel Signaling Pathways in the Islet Enhancing the Use of Prevention and Cardiovascular Risk Factor Control 10:15 a.m. 11:45 a.m. President, Medicine & Science Address and Banting Medal for Scientific Achievement Room: Hall WB4 12:00 p.m. 1:00 p.m. Mini- The Importance of the Functional Characteristics of HDL Mini- Update on Diabetic Retinopathy Clinical Trials Moving Past the Randomized Controlled Trial Understanding the Need for Implementation Science in Care The Future of Education Live Educator and Virtual Coach Partners in Care Beyond HbA1c in Pediatric Is It Time to Look at Other Outcomes? Clinical Centers and Programs Session I Mini- Update on the of Type 1 and Type 2 12:00 p.m. 1:00 p.m. General Poster Session/Moderated Poster Discussions Hall WA4-WB2 (Poster Hall)/Hall WA1-WA3 (Exhibit Hall) 1:00 p.m. 2:00 p.m. Session Break (Take this opportunity to visit the Exhibit and Poster Halls)
6 Registration Hours: 7:30 a.m. 5:00 p.m. Shop Store Hours: 7:30 a.m. 6:45 p.m. DAY-AT-A-GLANCE SCHEDULE SUNDAY, JUNE 24, 2018 WEAR RED DAY (CONTINUED) Exhibit Hall Hours: 10:00 a.m. 4:00 p.m. Poster Hall Hours: 7:30 a.m. 6:30 p.m. 2:15 p.m. 4:15 p.m. Joint ADA/ASN Management of Patients with Progressing Diabetic Kidney Disease (DKD) New Insights into the Mechanisms of Defective Hypoglycemia Counterregulation in (With ADA Presidents Select Abstract) Innovative Strategies to Improve the Inpatient Experience Aerobic Exercise in the Prevention of Cognitive Decline in The National Prevention Program From Research to Practice to National Policy Joint ADA/JDRF Current Management of Type 1 in Youth What Are the Options? Addressing Unique Challenges in Management (2:15 p.m. 3:00 p.m.) Kelly West Award for Outstanding Achievement in Epidemiology Lecture Joint ADA/ UK Cell Therapy for International Progress Fuel Driving Function Lipidic Roles in Different Tissues Ordering from the Weight- Loss Menu in the Era of Precision Medicine for Obesity More to Mitochondria in the Beta Cell Clinical Trials in Type 1 4:30 p.m. 6:30 p.m. Neuro- and Glial-Vascular Effects in the Pathogenesis of Diabetic Retinopathy The Veterans Affairs Trial (VADT) at 15 Years Low-Carbohydrate Diets Potential Benefits, Risks, and Costs High Risk Behavioral and Psychosocial Issues in Prevention What Are We Preventing? Joint ADA/AACC Refining Measurement of A1C Do We Know What It Means? Basic and Translational Mechanisms in Gestational Mellitus Academia-Industry Collaborations Key Considerations Beyond Single Nucleotide Polymorphisms Building on Knowledge of the Genetic Architecture of Novel Pathogenetic Pathways in Type 1 What Can We Learn from Cancer Immunotherapy? New Angles in Adipose Biology Joint ADA/EASD Central Control of Glucose Homeostasis Alpha Cells New Sources of Beta Cells? From Progression to Management in Type 1 What Is New? (With ADA Presidents Select Abstract)
7 MONDAY, JUNE 25, 2018 Registration Hours: 7:30 a.m. 4:00 p.m. Shop Store Hours: 7:30 a.m. 6:45 p.m. Exhibit Hall Hours: 10:00 a.m. 2:00 p.m. Poster Hall Hours: 7:30 a.m. 2:00 p.m. 8:00 a.m. 10:00 a.m. Role of the Kidney in Heart Health New Insights into the Pathogenesis of Diabetic Retinopathy Intervening in the Lived Experiences and Social Context of Those with Self-Management Education and Support Embracing Data and Digital Dialogue Advances Who Do You Think You Are? Heterogeneity of Obesity and Gestational Mellitus Type 2 in Youth Update on the Current State of Knowledge on Effectiveness of Telemedicine in Underserved Communities Genetic and Ethnic Heterogeneity and the Road to Precision Medicine in (With ADA Presidents Select Abstract) Clinical Trials for Type 1 Current, Emerging, and Novel Adipose Browning and Energy Expenditure (With State-of-the-Art Lecture) Recognition of Depression,, and Dementia Resetting Clinical Priorities Novel Mediators and Mechanisms of Obesity Pathogenesis in Animals Metabolism and the Beta Cell SGLT2 Inhibitors From Mechanisms to Clinical Trials (With ADA Presidents Select Abstract) 10:10 a.m. 11:45 a.m. 12:00 p.m. 1:00 p.m. 12:00 p.m. 1:00 p.m. 1:00 p.m. 2:00 p.m. Mini- Special Topics in Hypoglycemia Mini- Overcoming Gender Gaps in Science National Scientific & Health Care Achievement Awards Presentation and Outstanding Scientific Achievement Award Lecture Room: Hall WB4 The Lancet Commission on Societal Solutions to Combat Should All Pregnant Women with Type 1 Use Continuous Glucose Monitoring from Planning Pregnancy until after Breastfeeding? Clinical Centers and Programs Session II Group Session Defining a Healthy Diet Do Fats or Carbohydrates Matter More? Group Session Immunopathogenesis of Type 1 Is It Autoimmunity? General Poster Session/Moderated Poster Discussions Hall WA4-WB2 (Poster Hall)/Hall WA1-WA3 (Exhibit Hall) Session Break (Take this opportunity to visit the Exhibit and Poster Halls)
8 Registration Hours: 7:30 a.m. 4:00 p.m. Shop Store Hours: 7:30 a.m. 6:45 p.m. DAY-AT-A-GLANCE SCHEDULE MONDAY, JUNE 25, 2018 (CONTINUED) Exhibit Hall Hours: 10:00 a.m. 2:00 p.m. Poster Hall Hours: 7:30 a.m. 2:00 p.m. 2:15 p.m. 4:15 p.m. Evolving Mechanisms in Cardiovascular (With Edwin Bierman Award Lecture) Easing Disease Management Burden for Older Adults Nutrition 2018 New Data, New Perspectives Cost-Related Nonadherence to Care The Restoring Insulin Secretion (RISE) Study in Youth and Adults Baseline Data and Results of the Pediatric Medication Study Race and Societal Influences on (With Vivian Fonseca and Nagendran Family Research Award Presentation) Translational Immunology in Type 1 A Look at the Future Adipose Signaling and the Central Nervous System in the Control of Obesity Diversity Affairs Impact of Genetic Variability and Sex on Integrative Metabolism and Disease Risk Regulation of Islet Function in Health and Disease Preventing and Treating Hypoglycemia 4:30 p.m. 6:30 p.m. Current Issues Albuminuria Two Debates Clinical Strategies for Prevention and Management of Hypoglycemia New Insights into Lipid and Lipoprotein Alterations in Patients with and Psychosocial Risk Factors in the Hispanic Community Health Study/Study of Latinos Using mhealth for Obesity Treatment and Weight Management Insulin Therapy To the Future and Back Adiposity, Insulin Resistance, and Type 2 Mellitus What Is New in Risk Factors and Biomarkers? Innovations in Insulin Formulation and Delivery Mechanistic Insights from Rare Conditions and Opportunities for Novel Clinical Updates in Beta-Cell Replacement Therapy Novel Aspects of Metabolic Regulation (With ADA Presidents Select Abstract) Human Obesity Pathogenesis From Brain to Peripheral Organs Alphabet Soup GABA, FGF, ERα Recipe for Central Nervous System Control of Metabolic Homeostasis and Remission (With State-of-the-Art Lecture) The Islet in Type 1 What s New?
9 TUESDAY, JUNE 26, 2018 Registration Hours: 7:30 a.m. 10:30 a.m. Shop Store Hours: 7:30 a.m. 12:30 p.m. 8:00 a.m. 10:00 a.m. Cardiorenal Effects of Glucose-Lowering Therapies Multigenerational Effects of Exercise Management of in a Surgical Patient Obesity in Type 1 An Evolving Challenge in Rural America Aging and Insulin Sensitivity Nutrient Sensing and Signaling in the Regulation of Metabolic Homeostasis G-Protein-Coupled Receptors Structural Insights to Therapeutic Options Management of Hyperglycemia in Type 2 Draft ADA/EASD Consensus Report :15 a.m. 12:15 p.m. SGLT Inhibition for Type 1 Mellitus Management How Far Have We Gone?
Immunology/ Transplantation. Epidemiology/ Genetics. Mini-Symposium The Future Face of Diabetes Care Beta- Cell Replacement vs. Technology Room: 24
FRIDAY, JUNE 9 Registration Hours: 9:00 a.m.-6:30 p.m. Shop Store Hours: 9:00 a.m.-6:30 p.m. Clinical / 11:30 a.m.- 12:30 p.m. Mini- Clinical Innovation in Vision Mini- Exercise for Type 1 The Stigma of
More informationFRIDAY, JUNE 21. Epidemiology/ Genetics. Symposium The Big Picture Genetic Architecture of Diabetes Room S 103 B
Registration Hours: 9:00 a.m. 6:30 p.m. Shop Store Hours: 9:00 a.m. 6:30 p.m. FRIDAY, JUNE 21 Noon 12:40 p.m. Meet the Expert Sessions 12:50 p.m. 1:30 p.m. Meet the Expert Sessions 2:00 p.m. 4:00 p.m.
More informationEpidemiology/ Genetics. Immunology/ Transplantation
FRIDAY, JUNE 7 Registration Hours: 9:00 a.m.-6:30 p.m. Shop Store Hours: 9:00 a.m.-6:30 p.m. 12:30 p.m. Opioids, Cannabinoids, and Other Potentially Addictive Therapies in Painful Diabetic Neuropathy Hypoglycemia
More informationEXPERIENCE NEW HORIZONS IN DIABETES PRELIMINARY PROGRAM. scientificsessions.diabetes.org
EXPERIENCE NEW HORIZONS IN DIABETES PRELIMINARY PROGRAM scientificsessions.diabetes.org ABOUT THE MEETING The American Diabetes Association s Scientific Sessions offers researchers and health care professionals
More informationAmerican Diabetes Association Scientific Sessions Poster Presentation Guidelines. Table of Contents
American Diabetes Association Scientific Sessions Poster Presentation Guidelines Table of Contents Overview.... Page 2 Poster Display Guidelines...Page 2 Poster Design and Development....Pages 2-3 Prior
More informationscientificsessions.diabetes.org Preliminary Program
DIABETES BREAKTHROUGHS HAPPEN HERE scientificsessions.diabetes.org Preliminary Program About the Meeting The Scientific Sessions offers researchers and health care professionals the unique opportunity
More informationDIABETES BREAKTHROUGHS HAPPEN HERE
DIABETES BREAKTHROUGHS HAPPEN HERE scientificsessions.diabetes.org Advance Program ADVANCE PROGRAM ABOUT THE MEETING The Scientific Sessions offers researchers and health care professionals the unique
More informationPreliminary Program Outline
Saturday, June 2, 2018 1:00 pm 5:30 pm Pre-Meeting Symposia Advanced Immunology Basic Science for the Clinician The Immunology of Kidney Transplantation Transplant Center QAPI and Advanced Leadership:
More informationJanice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES
Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES Objectives u At conclusion of the lecture the participant will be able to: 1. Differentiate between the classifications of diabetes
More informationAmerican Diabetes Association Scientific Sessions Poster Presentation and Moderated Poster Discussion eposter Theater Guidelines.
American Diabetes Association Scientific Sessions Poster Presentation and Moderated Poster Discussion eposter Theater Guidelines Table of Contents Overview.............Page 2 Poster Display Guidelines...Page
More information2017 RESEARCH UPDATE A Year of Scientific Progress
2017 RESEARCH UPDATE A Year of Scientific Progress First, we need basic scientific understanding. Then we must translate that understanding into therapies that must then be tested and approved by regulators.
More informationWhat is Diabetes Mellitus?
Normal Glucose Metabolism What is Diabetes Mellitus? When the amount of glucose in the blood increases, After a meal, it triggers the release of the hormone insulin from the pancreas. Insulin stimulates
More informationWeek 3, Lecture 5a. Pathophysiology of Diabetes. Simin Liu, MD, ScD
Week 3, Lecture 5a Pathophysiology of Diabetes Simin Liu, MD, ScD General Model of Peptide Hormone Action Hormone Plasma Membrane Activated Nucleus Cellular Trafficking Enzymes Inhibited Receptor Effector
More informationDiabetes: What is the scope of the problem?
Diabetes: What is the scope of the problem? Elizabeth R. Seaquist MD Division of Endocrinology and Diabetes Department of Medicine Director, General Clinical Research Center Pennock Family Chair in Diabetes
More informationExercise Prescription in Type 1 Diabetes
Exercise Prescription in Type 1 Diabetes Michael Riddell, PhD Professor, Muscle Health Research Centre and School of Kinesiology & Health Science, York University Senior Scientist, LMC Diabetes & Endocrinology,
More informationDay at a Glance Schedule Saturday, April 22, 2017 Nutrition Across. Nutritional Nutrition
American Society for Scientific Sessions at EB 2017 Day at a Glance Schedule Friday, April 21, 2017 All functions will be held at the McCormick Place Convention Center unless otherwise indicated. Updated
More informationStandards of Medical Care in Diabetes 2016
Standards of Medical Care in Diabetes 2016 Care Delivery Systems 33-49% of patients still do not meet targets for A1C, blood pressure, or lipids. 14% meet targets for all A1C, BP, lipids, and nonsmoking
More informationRole of Academia In Achieving Targets in Diabetes Care
Role of Academia In Achieving Targets in Diabetes Care Disclosures Member of NovoNordisk, Lilly, Metavention, Sanofi, and Janssen Diabetes Advisory Boards Role of Academia in Discovering New Treatments
More informationCommonwealth Nurses Federation. Preventing NCDs: A primary health care response Risk factor No 1: Diabetes
Preventing NCDs: A primary health care response Risk factor No 1: Diabetes DIABETES: Definition Diabetes is a group of heterogeneous disorders with the common elements of hyperglycaemia and glucose intolerance
More informationType 2 DM in Adolescents: Use of GLP-1 RA. Objectives. Scope of Problem: Obesity. Background. Pathophysiology of T2DM
Type 2 DM in Adolescents: Use of GLP-1 RA Objectives Identify patients in the pediatric population with T2DM that would potentially benefit from the use of GLP-1 RA Discuss changes in glycemic outcomes
More informationDiabetes Complications Recognition and Treatment
Diabetes Complications Recognition and Treatment Edward Shahady MD, FAAFP, ABCL Clinical Professor Family Medicine Medical Director Diabetes Master Clinician Program Diabetes is the most difficult of all
More information5/16/2018. Beyond Patient Centered to Personalized Diabetes Care: Disclosures. Research Support. Advisory Panel
Beyond Patient Centered to Personalized Diabetes Care Jennifer B. Marks, MD, FACP, FACE Emeritus Professor of Medicine University of Miami Miller School of Medicine Diabetes Research Institute Former Director,
More informationObjectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015
Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015 Presentation downloaded from http://ce.unthsc.edu Objectives Understand that the obesity epidemic is also affecting children and adolescents
More informationPathogenesis of Diabetes Mellitus
Pathogenesis of Diabetes Mellitus Young-Bum Kim, Ph.D. Associate Professor of Medicine Harvard Medical School Definition of Diabetes Mellitus a group of metabolic diseases characterized by hyperglycemia
More informationSubject Index. postprandial glycemia and suppression in serum 51 recommendations 119, 120 supplementation pros and cons 118, 119
Acarbose, diabetes prevention trials 32, 33, 40 42 Accelerator hypothesis accelerators beta cell autoimmunity 140, 141, 147, 150, 151 insulin resistance 140, 142 144, 150 obesity 145 148 diabetes risk
More informationDiabetes Guidelines in View of Recent Clinical Trials Are They Still Applicable?
Diabetes Guidelines in View of Recent Clinical Trials Are They Still Applicable? Jay S. Skyler, MD, MACP Division of Endocrinology, Diabetes, and Metabolism and Diabetes Research Institute University of
More informationCommon Diabetes-related Terms
Common Diabetes-related Terms A1C An A1C test measures a person's average blood glucose level over two to three months. Hemoglobin is the part of a red blood cell that carries oxygen to the cells and sometimes
More informationChapter 37: Exercise Prescription in Patients with Diabetes
Chapter 37: Exercise Prescription in Patients with Diabetes American College of Sports Medicine. (2010). ACSM's resource manual for guidelines for exercise testing and prescription (6th ed.). New York:
More informationComplete Comprehensive Diabetes Educator modules available at CCCEP File #: I-P (Expires: Mar.
CDE Preparation Program Topics (Accredited by CCCEP for 0.5 CEUs/Module section Total = 20 CEUs) Module 1 Pathophysiology of Diabetes 5 segments Module 2 Diabetes and Nutrition 5 segments Module 3 Medications
More informationALOPECIA AREATA RESEARCH SUMMIT Forging the Future
ALOPECIA AREATA RESEARCH SUMMIT Forging the Future PRELIMINARY PROGRAM Tuesday, December 4 Wednesday, December 5, 2018 Lerner Hall, Columbia University, New York City, USA Summit Co-Chairs Jerry Shapiro,
More informationIMIDIA IMPROVING BETA-CELL FUNCTION AND IDENTIFICATION OF DIAGNOSTIC BIOMARKERS FOR TREATMENT MONITORING IN DIABETES. A. Ktorza, B.
IMIDIA IMPROVING BETA-CELL FUNCTION AND IDENTIFICATION OF DIAGNOSTIC BIOMARKERS FOR TREATMENT MONITORING IN DIABETES A. Ktorza, B. Thorens DIABETES Definition Diabetes is a metabolic disease characterized
More informationALOPECIA AREATA RESEARCH SUMMIT Forging the Future
ALOPECIA AREATA RESEARCH SUMMIT Forging the Future PRELIMINARY PROGRAM Tuesday, December 4 Wednesday, December 5, 2018 Lerner Hall, Columbia University, New York City, USA Summit Co-Chairs Jerry Shapiro,
More informationJDRF RESEARCH UPDATE. Daniel Finan, Ph.D. Research Director
JDRF RESEARCH UPDATE Daniel Finan, Ph.D. Research Director March 10, 2018 PRESENTER Daniel Finan Biomedical engineer B.S. Chemical Engineering University of Colorado, 2003 Ph.D. Chemical Engineering UC
More informationIndividualizing Type 2 Diabetes Management. Cynthia Gerstenlauer, ANP-BC, GCNS-BC, CDE, CCD
Individualizing Type 2 Diabetes Management Cynthia Gerstenlauer, ANP-BC, GCNS-BC, CDE, CCD Harsh Statistics 30.3 million (9.4% of population) in US had DM in 2015 The percent of population with DM increases
More informationClinical Practice Guidelines for Diabetes Management
Clinical Practice Guidelines for Diabetes Management Diabetes is a disease in which blood glucose levels are above normal. Over the years, high blood glucose damages nerves and blood vessels, which can
More informationTUESDAY, MARCH 26, 2019 WEDNESDAY, MARCH 27, 2019
KEY: PRE CONFERENCE SYMPOSIUM SPONSORED SYMPOSIUM SYMPOSIUM PLENARY LECTURE FORUM OTHER EVENT *PRE-REGISTRATION IS REQUIRED FOR THE INFORMAL NETWORKING WITH PROFESSOR LUNCH SESSION TUESDAY, MARCH 26, 2019
More informationLegend. Innovations in Treatment and Recovery. Industry Symposia Oral Communications E Short Communications SUNDAY FEBRUARY 25, 2018
Legend Plenary Innovations in Neuroscience Innovations in Treatment and Recovery Innovations in Thinking Innovations in Technologies Innovations in Policy and Planning Health Industry Symposia Oral Communications
More informationTUESDAY, MARCH 26, 2019 WEDNESDAY, MARCH 27, 2019
KEY: PRE CONFERENCE SYMPOSIUM SPONSORED SYMPOSIUM SYMPOSIUM PLENARY LECTURE FORUM OTHER EVENT *PRE-REGISTRATION IS REQUIRED FOR THE INFORMAL NETWORKING WITH PROFESSOR LUNCH SESSION TUESDAY, MARCH 26, 2019
More informationCoding spotlight: diabetes provider guide to coding the diagnosis and treatment of diabetes
Medicaid Managed Care December 2018 provider guide to coding the diagnosis and treatment of diabetes Diabetes mellitus is a chronic disorder caused by either an absolute decrease in the amount of insulin
More informationGestational Diabetes: Long Term Metabolic Consequences. Outline 5/27/2014
Gestational Diabetes: Long Term Metabolic Consequences Gladys (Sandy) Ramos, MD Associate Clinical Professor Maternal Fetal Medicine Outline Population rates of obesity and T2DM Obesity and metabolic syndrome
More information9.3 Stress Response and Blood Sugar
9.3 Stress Response and Blood Sugar Regulate Stress Response Regulate Blood Sugar Stress Response Involves hormone pathways that regulate metabolism, heart, rate and breathing The Adrenal Glands a pair
More informationHelpful Hints for Taking Care of Your Diabetes. Farahnaz Joarder, MD and Don Kain, MA, RD,CDE Harold Schnitzer Diabetes Health Center
Helpful Hints for Taking Care of Your Diabetes Farahnaz Joarder, MD and Don Kain, MA, RD,CDE Harold Schnitzer Diabetes Health Center Objectives How big of a problem is diabetes? What is diabetes? How is
More informationFuture of Diabetes Research in Europe JDRF Perspective
Future of Diabetes Research in Europe JDRF Perspective IMI-JDRF Diabetes Patient Meeting 20 May 2014 Brussels, Belgium Olivier ARNAUD, Pharm D JDRF European Research Director oarnaud@jdrf.org Future of
More informationType 2 Diabetes in Adolescents
Type 2 Diabetes in Adolescents Disclosures Paid consultant, Eli Lilly, Inc, Pediatric Type 2 Diabetes Clinical Trials Outline The burden of diabetes Treatment and Prevention Youth Diabetes Prevention Clinic
More information10/27/2016. Processing in the Large Intestine. The colon of the large intestine is connected to the small intestine
The hepatic portal vein carries nutrient-rich blood from the capillaries of the villi to the liver, then to the heart The liver regulates nutrient distribution, interconverts many organic molecules, and
More informationAmylin Pharmaceuticals: Creating Value as a Leader in the Treatment of Diabetes
Amylin Pharmaceuticals: Creating Value as a Leader in the Treatment of Diabetes Daniel M. Bradbury President & Chief Executive Officer JPMorgan Healthcare Conference January 12, 2009 Safe Harbor Statement
More informationUNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY AND MOLECULAR BIOLOGY
1 UNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY AND MOLECULAR BIOLOGY GLUCOSE HOMEOSTASIS An Overview WHAT IS HOMEOSTASIS? Homeostasis
More informationProvider Bulletin December 2018 Coding spotlight: diabetes provider guide to coding the diagnosis and treatment of diabetes
Medi-Cal Managed Care L. A. Care Provider Bulletin December 2018 provider guide to coding the diagnosis and treatment of diabetes Diabetes mellitus is a chronic disorder caused by either an absolute decrease
More informationHormonal Regulations Of Glucose Metabolism & DM
Hormonal Regulations Of Glucose Metabolism & DM What Hormones Regulate Metabolism? What Hormones Regulate Metabolism? Insulin Glucagon Thyroid hormones Cortisol Epinephrine Most regulation occurs in order
More informationHistory of Investigation
Acini - Pancreatic juice (1º) (2º) Secretions- neuronal and hormonal mechanisms 1) Secretin - bicarbonate rich 2) Cholecystokinin - enzyme rich Islets of Langerhans (contain 4 cell types) Alpha cells (α)-
More informationDiabetes Pathophysiology and Treatment Strategies
Lehigh Valley Health Network LVHN Scholarly Works Department of Family Medicine Diabetes Pathophysiology and Treatment Strategies Beth Careyva MD Lehigh Valley Health Network, beth_a.careyva@lvhn.org Follow
More informationDiabetes Mellitus. Medical Management and Latest Developments Dr Ahmad Abou-Saleh
Diabetes Mellitus Medical Management and Latest Developments Dr Ahmad Abou-Saleh What is Diabetes Mellitus? A disease characterised by a state of chronic elevation of blood glucose levels due to: - The
More informationEndocrine System. Regulating Blood Sugar. Thursday, December 14, 17
Endocrine System Regulating Blood Sugar Stress results in nervous and hormonal responses. The adrenal glands are located above each kidney. Involved in stress response. Stress Upsets Homeostasis Stress
More informationStandards of Medical Care In Diabetes
Standards of Medical Care In Diabetes - 2017 Robert E. Ratner, MD, FACP, FACE Professor of Medicine Georgetown University School of Medicine Disclosed no conflict of interest Standards of Care Professional.diabetes.org/SOC
More informationDiabetes: Across the Lifespan Friday, October 17, Obesity, Insulin Resistance and Type 2 Diabetes Cardiovascular Risks in Children.
Diabetes: Across the Lifespan Friday, October 17, 2014 Obesity, Insulin Resistance and Type 2 Diabetes Cardiovascular Risks in Children. Don P. Wilson, M.D., FNLA Diplomate, Am Brd of Clinical Lipidology
More informationDiabetes 2013: Achieving Goals Through Comprehensive Treatment. Session 2: Individualizing Therapy
Diabetes 2013: Achieving Goals Through Comprehensive Treatment Session 2: Individualizing Therapy Joshua L. Cohen, M.D., F.A.C.P. Professor of Medicine Interim Director, Division of Endocrinology & Metabolism
More informationWhat is Metabolic About Metabolic Surgery? The New ADA Recommendations
What is Metabolic About Metabolic Surgery? The New ADA Recommendations Obesity Symposium September 16, 2017 Timothy Howland, MD Lourdes Endocrinology Bariatric from the Greek root bar- ("weight" as in
More informationWelcome and Introduction
Welcome and Introduction This presentation will: Define obesity, prediabetes, and diabetes Discuss the diagnoses and management of obesity, prediabetes, and diabetes Explain the early risk factors for
More informationPersonalized therapeutics in diabetes
Personalized therapeutics in diabetes Leen M. t Hart Molecular Cell Biology & Molecular Epidemiology Leiden University Medical Center Epidemiology & Biostatistics VU University Medical Center Diabetes
More informationWayne Gravois, MD August 6, 2017
Wayne Gravois, MD August 6, 2017 Americans with Diabetes (Millions) 40 30 Source: National Diabetes Statistics Report, 2011, 2017 Millions 20 10 0 1980 2009 2015 2007 - $174 Billion 2015 - $245 Billion
More informationBackground-why this programme?
Background-why this programme? The health burden of diabetes Financial issues/risk to the NHS in LLR Improving quality and cost effectiveness of diabetes services to 130 billion From 44 billion A real
More informationDiabetes Overview. How Food is Digested
Diabetes Overview You are The Teacher, The Coach and the Fan Pathophysiology of Diabetes Complications Know the Numbers Treatment Can Good Control Make a Difference? Can Tight Control Be too Tight? How
More informationObjectives 10/11/2013. Diabetes- The Real Cost of Sugar. Diabetes 101: What is Diabetes. By Ruth Nekonchuk RD CDE LMNT
Diabetes- The Real Cost of Sugar By Ruth Nekonchuk RD CDE LMNT Objectives To explain diabetes To explain the risks of diabetes To enumerate the cost of diabetes to our country To enumerate the cost of
More informationBPA exposure during pregnancy: risk for gestational diabetes and diabetes following pregnancy
BPA exposure during pregnancy: risk for gestational diabetes and diabetes following pregnancy Paloma Alonso-Magdalena Applied Biology Department and CIBERDEM, Miguel Hernández University, Elche, Spain
More informationVIENNA HEART M AY FAILURE ADVANCE PROGRAMME. World Congress on Acute Heart Failure. Organised by the Heart Failure Association of the ESC
Organised by the Heart Failure Association of the ESC HEART 2018 FAILURE including the 2 6-2 9 M AY VIENNA ADVANCE PROGRAMME www.escardio.org/heartfailure WELCOME Heart Failure is the world s leading congress
More informationStandards of Care in Diabetes What's New? Veronica Brady, FNP-BC, PhD, BC-ADM,CDE Karmella Thomas, RD, LD,CDE
Standards of Care in Diabetes 2016-- What's New? Veronica Brady, FNP-BC, PhD, BC-ADM,CDE Karmella Thomas, RD, LD,CDE Terminology No longer using the term diabetic. Diabetes does not define people. People
More informationObjectives. Diabetes in Pregnancy: A Growing Dilemma. Diabetes in the US 10/6/2015. Disclosure. The presenter has no conflicts to disclose
Diabetes in Pregnancy: A Growing Dilemma Kathy O Connell, MN RN Perinatal Clinical Nurse Specialist University of Washington Medical Center Seattle, WA koconnll@uw.edu Objectives Describe pathophysiologic
More informationWhat systems are involved in homeostatic regulation (give an example)?
1 UNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY AND MOLECULAR BIOLOGY GLUCOSE HOMEOSTASIS (Diabetes Mellitus Part 1): An Overview
More informationDIABETES. A growing problem
DIABETES A growing problem Countries still grappling with infectious diseases such as tuberculosis, HIV/AIDS and malaria now face a double burden of disease Major social and economic change has brought
More informationThe Dual Hormonal Artificial Pancreas in Diabetes Management. Medical Innovation Day Challenge
The Dual Hormonal Artificial Pancreas in Diabetes Management Medical Innovation Day Challenge 1 Background for the challenge A paradigm shift in treating diabetes Zealand Pharma is a Danish biotech company
More informationDOWNLOAD OR READ : THE TYPE 2 DIABETES CURE PDF EBOOK EPUB MOBI
DOWNLOAD OR READ : THE TYPE 2 DIABETES CURE PDF EBOOK EPUB MOBI Page 1 Page 2 the type 2 diabetes cure the type 2 diabetes pdf the type 2 diabetes cure Diabetes is a problem with your body that causes
More informationassociated with serious complications, but reduce occurrences with preventive measures
Wk 9. Management of Clients with Diabetes Mellitus 1. Diabetes Mellitus body s inability to metabolize carbohydrates, fats, proteins hyperglycemia associated with serious complications, but reduce occurrences
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Diabetes in children and young people: diagnosis and management of type 1 and type 2 diabetes in children and young people
More informationNormal Fuel Metabolism Five phases of fuel homeostasis have been described A. Phase I is the fed state (0 to 3.9 hours after meal/food consumption),
Normal Fuel Metabolism Five phases of fuel homeostasis have been described A. Phase I is the fed state (0 to 3.9 hours after meal/food consumption), in which blood glucose predominantly originates from
More informationThe Many Faces of T2DM in Long-term Care Facilities
The Many Faces of T2DM in Long-term Care Facilities Question #1 Which of the following is a risk factor for increased hypoglycemia in older patients that may suggest the need to relax hyperglycemia treatment
More informationPsychosocial Issues for People with Diabetes. Richard Arakaki, M.D. Phoenix Area Diabetes Consultant June 28, 2017
Psychosocial Issues for People with Diabetes Richard Arakaki, M.D. Phoenix Area Diabetes Consultant June 28, 2017 Objectives Provide epidemiological and interventional data of DM in AI/AN and general population
More informationType 2 Diabetes. Treat to: limit complications maintain quality of life Improve survival
Type 2 Diabetes Treat to: limit complications maintain quality of life Improve survival 1 Criteria for the diagnosis of diabetes 1. HbA1C 6.5% (rounded to 50mmol/mol). 2. FPG 7.0 mmol/l. 3. 2-h plasma
More informationQUESTION 4. WHAT CLINICAL DATA ARE CURRENTLY AVAILABLE TO SUPPORT EXPANDED CGM COVERAGE BY PAYERS AS PERTAINS TO QUESTIONS 1 AND 3?
500 1 QUESTION 4. WHAT CLINICAL DATA ARE CURRENTLY AVAILABLE TO SUPPORT EXPANDED CGM COVERAGE BY PAYERS AS PERTAINS TO QUESTIONS 1 AND 3? WHAT ADDITIONAL DATA ARE NEEDED? AACE/ACE CGM Consensus Conference:
More informationLaboratory analysis of the obese child recommendations and discussion. MacKenzi Hillard May 4, 2011
Laboratory analysis of the obese child recommendations and discussion MacKenzi Hillard May 4, 2011 aka: What to do with Fasting Labs The Obesity Epidemic The prevalence of obesity in adolescents has tripled
More informationWhy do we care? 20.8 million people. 70% of people with diabetes will die of cardiovascular disease. What is Diabetes?
What is Diabetes? Diabetes 101 Ginny Burns RN MEd CDE Diabetes mellitus is a group of diseases characterized by high levels of blood glucose resulting from defects in insulin production, insulin action
More informationThe Realities of Technology in Type 1 Diabetes
The Realities of Technology in Type 1 Diabetes May 6, 2017 Rosanna Fiallo-scharer, MD Margaret Frederick, RN Disclosures I have no conflicts of interest to disclose I will discuss some unapproved treatments
More informationENERGY FROM INGESTED NUTREINTS MAY BE USED IMMEDIATELY OR STORED
QUIZ/TEST REVIEW NOTES SECTION 1 SHORT TERM METABOLISM [METABOLISM] Learning Objectives: Identify primary energy stores of the body Differentiate the metabolic processes of the fed and fasted states Explain
More informationLiving Well with Diabetes
Living Well with Diabetes What is diabetes? Diabetes Overview Diabetes is a disorder of the way the body uses food for growth and energy. Most of the food people eat is broken down into glucose, the form
More informationWhat s New in the Standards of Medical Care in Diabetes? Dr. Jason Kruse, DO Broadlawns Medical Center
What s New in the Standards of Medical Care in Diabetes? Dr. Jason Kruse, DO Broadlawns Medical Center Learning Objectives By the end of this presentation, participants should be able to: Discuss updates
More informationDIAGNOSIS OF DIABETES NOW WHAT?
DIAGNOSIS OF DIABETES NOW WHAT? DISCUSS GOALS FOR DIABETES CARE IDENTIFY COMMON COMPLIANCE- ADHERENCE ISSUES DESCRIBE TECHNOLOGY TO ASSIST AND / OR IMPROVE DIABETES CARE WHAT DO WE WANT OUR PATIENTS TO
More informationDiabesity. Metabolic dysfunction that ranges from mild blood glucose imbalance to full fledged Type 2 DM Signs
Diabesity Metabolic dysfunction that ranges from mild blood glucose imbalance to full fledged Type 2 DM Signs Abdominal obesity Low HDL, high LDL, and high triglycerides HTN High blood glucose (F>100l,
More informationDiabetes Mellitus. Disclaimer. Multimedia Health Education
Disclaimer This movie is an educational resource only and should not be used to manage Diabetes or blood sugar control.all decisions about management of diabetes must be made in conjunction with your Physician
More informationGESTATIONAL DIABETES: An Overview
GESTATIONAL DIABETES: An Overview University of Papua New Guinea School of Medicine & Health Sciences, Division of Basic Medical Sciences Clinical Biochemistry: PBL Seminar MBBS Yr 4 VJ Temple 1 Brief
More informationGlucose Homeostasis. Liver. Glucose. Muscle, Fat. Pancreatic Islet. Glucose utilization. Glucose production, storage Insulin Glucagon
Glucose Homeostasis Liver Glucose Glucose utilization Glucose production, storage Insulin Glucagon Muscle, Fat Pancreatic Islet Classification of Diabetes Type 1 diabetes Type 2 diabetes Other types of
More informationThursday 25 October. Hall A
Thursday 25 October Hall A 14:00-15:15 : Neuropathy Diabetic neuropathy: Newer insights into pathogenesis and management Can we prevent diabetic neuropathy? Motor neuropathy: A neglected complication of
More information18. PANCREATIC FUNCTION AND METABOLISM. Pancreatic secretions ISLETS OF LANGERHANS. Insulin
18. PANCREATIC FUNCTION AND METABOLISM ISLETS OF LANGERHANS Some pancreatic functions have already been discussed in the digestion section. In this one, the emphasis will be placed on the endocrine function
More informationDay-at-a-Glance. Saturday, June 2, 2018
Saturday, June 2, 2018 1:00 pm 5:30 pm Pre-Meeting Symposia (Additional Fee) Advanced Immunology Basic Science for the Clinician The Immunology of Kidney Transplantation Transplant Center QAPI and Advanced
More informationBREAKS NETWORKING EVENTS PARALLEL SESSIONS INDUSTRY SUPPORTED SESSIONS Academy of Autoimmunity SYMPOSIUM
PLENARY SESSIONS BREAKS NETWORKING EVENTS PARALLEL SESSIONS INDUSTRY SUPPORTED SESSIONS SYMPOSIUM Monday, 14 May 2018 13:00-15:30 15:30 16:00 COFFEE BREAK 16:00-17:30 Tuesday, 15 May 2018 08:00-08:30 08:30-10:30
More informationDIABETES TECHNOLOGY: WHERE ARE WE NOW AND WHERE ARE WE GOING? Presented by: Tom Brobson
DIABETES TECHNOLOGY: WHERE ARE WE NOW AND WHERE ARE WE GOING? Presented by: Tom Brobson March 3 rd, 2018 Who is this guy? Accelerating Progress 1 Oh that guy! Accelerating Progress 2 STATE OF T1D CARE
More informationIMI2 T1DM Call Topic Text: Translational approaches to disease modifying therapy of T1DM
IMI2 T1DM Call Topic Text: Translational approaches to disease modifying therapy of T1DM Dr Anke M Schulte, Head of Islet Biology Department Sanofi-Diabetes Frankfurt, Germany 11th of July, 2014 General
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 4,000 116,000 120M Open access books available International authors and editors Downloads Our
More informationThe Endocrine Pancreas (Chapter 10) *
OpenStax-CNX module: m62118 1 The Endocrine Pancreas (Chapter 10) * Ildar Yakhin Based on The Endocrine Pancreas by OpenStax This work is produced by OpenStax-CNX and licensed under the Creative Commons
More informationCME Post Test. D. Treatment with insulin E. Age older than 55 years
CME Post Test Translational Endocrinology & Metabolism: Metabolic Surgery Update Please select the best answer to each question on the online answer sheet. Go to http://www.endojournals.org/translational/
More informationHOW TO DEFINE GOOD BIOMARKERS OF HEALTH? Suzan Wopereis
HOW TO DEFINE GOOD BIOMARKERS OF HEALTH? Suzan Wopereis My personal objective: identification of biomarkers of (optimal) health Biomarker Definition: a characteristic that is objectively measured and evaluated
More information